Alcon acquires Sirion products - Ophthalmology Times Europe

Links shared publicly online about this topic.

1,404
total visits

Alcon acquires Sirion products - Ophthalmology Times Europe

Alcon is to buy the rights in the United States for two FDA-approved topical eye care products from Sirion Therapeutics, Inc Durezol, a marketed ophthalmic corticosteroid approved for the treatment of inflammation and pain associated with eye surgery, and Zirgan, a recently approved antiviral for the treatment of acute herpetic keratitis (corneal ulcers).

View full resource at oteurope.com

Tags: Pain, Eye, Eye Care, Alcon, Ophthalmology, Surgery, Corneal Ulcer